$JNJ
JOHNSON & JOHNSON Stock $jnj

$jnj Overview Financials Valuation SEC Filings Company Website

2017 Q1 Form 10-K Financial Statement

#000020040617000006 Filed on February 27, 2017

Income Statement

Concept	2017 Q1	2016 Q1	2015 Q3
Revenue	$18.11B	$17.81B	$17.10B
YoY Change	1.66%	2.52%	-7.39%
Cost Of Revenue	$5.516B	$5.673B	$5.224B
YoY Change	-2.77%	7.4%	-3.24%
Gross Profit	$12.57B	$12.14B	$11.88B
YoY Change	3.58%	0.38%	-9.11%
Gross Profit Margin	69.44%	68.15%	69.45%
Selling, General & Admin	$5.309B	$5.891B	$5.081B
YoY Change	-9.88%	21.54%	-7.08%
% of Gross Profit	42.23%	48.53%	42.78%
Research & Development	$2.640B	$2.865B	$2.154B
YoY Change	-7.85%	50.87%	6.48%
% of Gross Profit	21.0%	23.6%	18.13%
Depreciation & Amortization	$1.055B	$1.033B	$929.0M
YoY Change	2.13%	15.42%	-1.06%
% of Gross Profit	8.39%	8.51%	7.82%
Operating Expenses	$7.839B	$7.618B	$7.235B
YoY Change	2.9%	12.93%	-3.42%
Operating Profit	$4.733B	$4.520B	$4.643B
YoY Change	4.71%	-22.43%	-34.17%
Interest Expense	-$129.0M	-$39.00M	$123.0M
YoY Change	230.77%	-128.26%	-5.38%
% of Operating Profit	-2.73%	-0.86%	2.65%
Other Income/Expense, Net			-$420.0M
YoY Change			-131.23%
Pretax Income	$4.324B	$3.758B	$4.122B
YoY Change	15.06%	-32.59%	-39.47%
Income Tax	$510.0M	$543.0M	$764.0M
% Of Pretax Income	11.79%	14.45%	18.53%
Net Earnings	$3.814B	$3.215B	$3.358B
YoY Change	18.63%	-25.58%	-29.29%
Net Earnings / Revenue	21.06%	18.05%	19.64%
Basic Earnings Per Share	$1.41		$1.21
Diluted Earnings Per Share	$1.38	$1.148M	$1.20
COMMON SHARES
Basic Shares Outstanding	2.713B shares	2.759B shares	2.768B shares
Diluted Shares Outstanding			2.807B shares

Balance Sheet

Concept	2017 Q1	2016 Q1	2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$41.91B	$38.38B	$37.31B
YoY Change	9.2%	-11.39%	13.03%
Cash & Equivalents	$18.97B	$13.73B	$13.64B
Short-Term Investments	$22.94B	$24.64B	$23.67B
Other Short-Term Assets	$3.282B	$3.047B	$6.616B
YoY Change	7.71%	-58.0%	-4.59%
Inventory	$8.144B	$8.053B	$8.206B
Prepaid Expenses
Receivables	$11.70B	$10.73B	$11.37B
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$65.03B	$60.21B	$63.49B
YoY Change	8.01%	3.47%	5.87%
LONG-TERM ASSETS
Property, Plant & Equipment	$15.91B	$15.91B	$15.55B
YoY Change	0.04%	3.52%	-1.6%
Goodwill	$22.81B	$21.63B	$21.28B
YoY Change	5.44%	1.33%	-1.65%
Intangibles	$26.88B	$25.76B	$25.99B
YoY Change	4.32%	-4.67%	-1.2%
Long-Term Investments
YoY Change
Other Assets	$4.435B	$4.413B	$3.804B
YoY Change	0.5%	22.41%	-24.42%
Total Long-Term Assets	$76.18B	$73.20B	$69.77B
YoY Change	4.06%	3.98%	-3.26%
TOTAL ASSETS
Total Short-Term Assets	$65.03B	$60.21B	$63.49B
Total Long-Term Assets	$76.18B	$73.20B	$69.77B
Total Assets	$141.2B	$133.4B	$133.3B
YoY Change	5.84%	3.75%	0.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.918B	$6.668B	$5.928B
YoY Change	3.75%	-0.76%	-10.22%
Accrued Expenses	$5.635B	$5.411B	$5.062B
YoY Change	4.14%	-2.94%	-18.2%
Deferred Revenue
YoY Change
Short-Term Debt	$4.684B	$7.004B	$5.677B
YoY Change	-33.12%	73.15%	168.42%
Long-Term Debt Due	$1.700B	$7.004B	$5.677B
YoY Change	-75.73%	73.15%	168.42%
Total Short-Term Liabilities	$26.29B	$27.75B	$25.26B
YoY Change	-5.26%	16.41%	9.91%
LONG-TERM LIABILITIES
Long-Term Debt	$22.44B	$12.86B	$14.07B
YoY Change	74.55%	-13.93%	7.0%
Other Long-Term Liabilities	$9.536B	$10.24B	$9.303B
YoY Change	-6.88%	19.03%	19.91%
Total Long-Term Liabilities	$31.98B	$23.10B	$23.38B
YoY Change	38.44%	-1.89%	11.79%
TOTAL LIABILITIES
Total Short-Term Liabilities	$26.29B	$27.75B	$25.26B
Total Long-Term Liabilities	$31.98B	$23.10B	$23.38B
Total Liabilities	$70.79B	$62.26B	$61.71B
YoY Change	13.7%	2.55%	11.18%
SHAREHOLDERS EQUITY
Retained Earnings	$110.6B	$103.9B	$102.7B
YoY Change	6.42%	5.29%	6.41%
Common Stock	$3.120B	$3.120B	$3.120B
YoY Change	0.0%	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$28.35B	$22.68B	$21.45B
YoY Change	24.99%	10.13%	21.16%
Treasury Stock Shares	413.3M shares	364.7M shares	352.6M shares
Shareholders Equity	$70.42B	$71.15B	$71.55B
YoY Change
Total Liabilities & Shareholders Equity	$141.2B	$133.4B	$133.3B
YoY Change	5.84%	3.75%	0.88%

Cashflow Statement

Concept	2017 Q1	2016 Q1	2015 Q3
OPERATING ACTIVITIES
Net Income	$3.814B	$3.215B	$3.358B
YoY Change	18.63%	-25.58%	-29.29%
Depreciation, Depletion And Amortization	$1.055B	$1.033B	$929.0M
YoY Change	2.13%	15.42%	-1.06%
Cash From Operating Activities	$6.653B	$5.372B	$5.853B
YoY Change	23.85%	87.05%	25.76%
INVESTING ACTIVITIES
Capital Expenditures	-$1.093B	-$1.366B	-$789.0M
YoY Change	-19.99%	-351.57%	5.06%
Acquisitions
YoY Change
Other Investing Activities	-$1.081B	-$25.00M	-$212.0M
YoY Change	4224.0%	-327.27%	-114.27%
Cash From Investing Activities	-$2.174B	-$1.391B	-$1.001B
YoY Change	56.29%	-22.25%	-236.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-3.464B	-3.581B	-1.553B
YoY Change	-3.27%	10.97%	-72.83%
NET CHANGE
Cash From Operating Activities	6.653B	5.372B	5.853B
Cash From Investing Activities	-2.174B	-1.391B	-1.001B
Cash From Financing Activities	-3.464B	-3.581B	-1.553B
Net Change In Cash	1.015B	400.0M	3.299B
YoY Change	153.75%	-118.66%	-1108.87%
FREE CASH FLOW
Cash From Operating Activities	$6.653B	$5.372B	$5.853B
Capital Expenditures	-$1.093B	-$1.366B	-$789.0M
Free Cash Flow	$7.746B	$6.738B	$6.642B
YoY Change	14.96%	189.31%	22.89%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017	dei	Amendment Flag AmendmentFlag	false
CY2017	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-01
CY2017	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2017Q1	jnj	Defined Benefit Plan Expected Future Benefit Contribution In Five Fiscal Years Thereafter DefinedBenefitPlanExpectedFutureBenefitContributionInFiveFiscalYearsThereafter	610000000	USD
CY2017Q1	jnj	Defined Benefit Plan Expected Future Benefit Contribution In Year Five DefinedBenefitPlanExpectedFutureBenefitContributionInYearFive	100000000	USD
CY2017Q1	jnj	Defined Benefit Plan Expected Future Benefit Contribution In Year Four DefinedBenefitPlanExpectedFutureBenefitContributionInYearFour	94000000	USD
CY2017Q1	jnj	Defined Benefit Plan Expected Future Benefit Contribution In Year One DefinedBenefitPlanExpectedFutureBenefitContributionInYearOne	83000000	USD
CY2017Q1	jnj	Defined Benefit Plan Expected Future Benefit Contribution In Year Three DefinedBenefitPlanExpectedFutureBenefitContributionInYearThree	89000000	USD
CY2017	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2017	dei	Document Period End Date DocumentPeriodEndDate	2017-01-01
CY2017	dei	Document Type DocumentType	10-K
CY2017	dei	Entity Central Index Key EntityCentralIndexKey	0000200406
CY2017Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2713346602	shares
CY2017	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2017	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2016Q3	dei	Entity Public Float EntityPublicFloat	332000000000	USD
CY2017	dei	Entity Registrant Name EntityRegistrantName	JOHNSON & JOHNSON
CY2017	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2017	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2016Q1	jnj	Accrued Rebates Returns And Promotions AccruedRebatesReturnsAndPromotions	5440000000	USD
CY2017Q1	jnj	Accrued Rebates Returns And Promotions AccruedRebatesReturnsAndPromotions	5403000000	USD
	jnj	After Tax Restructuring Charge AfterTaxRestructuringCharge	415000000	USD
CY2016Q2	jnj	After Tax Restructuring Charge AfterTaxRestructuringCharge	120000000	USD
CY2016Q3	jnj	After Tax Restructuring Charge AfterTaxRestructuringCharge	97000000	USD
CY2016Q4	jnj	After Tax Restructuring Charge AfterTaxRestructuringCharge	76000000	USD
CY2017Q1	jnj	After Tax Restructuring Charge AfterTaxRestructuringCharge	251000000	USD
CY2016	jnj	Cumulative Amount Of Undistributed International Earnings CumulativeAmountOfUndistributedInternationalEarnings	58000000000	USD
CY2017	jnj	Cumulative Amount Of Undistributed International Earnings CumulativeAmountOfUndistributedInternationalEarnings	66200000000	USD
CY2016Q1	jnj	Deferred Tax Assets International Research And Development Capitalized DeferredTaxAssetsInternationalResearchAndDevelopmentCapitalized	1318000000	USD
CY2017Q1	jnj	Deferred Tax Assets International Research And Development Capitalized DeferredTaxAssetsInternationalResearchAndDevelopmentCapitalized	1264000000	USD
CY2016Q1	jnj	Deferred Tax Assets Other Domestic DeferredTaxAssetsOtherDomestic	436000000	USD
CY2017Q1	jnj	Deferred Tax Assets Other Domestic DeferredTaxAssetsOtherDomestic	155000000	USD
CY2017Q1	jnj	Defined Benefit Plan Expected Future Benefit Contribution In Year Two DefinedBenefitPlanExpectedFutureBenefitContributionInYearTwo	84000000	USD
CY2014	jnj	Depreciation Expense Including Amortization Of Capitalized Interest DepreciationExpenseIncludingAmortizationOfCapitalizedInterest	2500000000	USD
CY2016	jnj	Depreciation Expense Including Amortization Of Capitalized Interest DepreciationExpenseIncludingAmortizationOfCapitalizedInterest	2500000000	USD
CY2017	jnj	Depreciation Expense Including Amortization Of Capitalized Interest DepreciationExpenseIncludingAmortizationOfCapitalizedInterest	2500000000	USD
CY2014	jnj	Effective Income Tax Rate Reconciliation Foreign EffectiveIncomeTaxRateReconciliationForeign	-0.069
CY2016	jnj	Effective Income Tax Rate Reconciliation Foreign EffectiveIncomeTaxRateReconciliationForeign	-0.087
CY2017	jnj	Effective Income Tax Rate Reconciliation Foreign EffectiveIncomeTaxRateReconciliationForeign	-0.078
CY2014	jnj	Effective Income Tax Rate Reconciliation Related To Domestic Tax On International Income EffectiveIncomeTaxRateReconciliationRelatedToDomesticTaxOnInternationalIncome	0.014
CY2016	jnj	Effective Income Tax Rate Reconciliation Related To Domestic Tax On International Income EffectiveIncomeTaxRateReconciliationRelatedToDomesticTaxOnInternationalIncome	0.002
CY2017	jnj	Effective Income Tax Rate Reconciliation Related To Domestic Tax On International Income EffectiveIncomeTaxRateReconciliationRelatedToDomesticTaxOnInternationalIncome	0.013
CY2017	jnj	Effective Income Tax Rate Reconciliation Sharebased Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationSharebasedCompensationExcessTaxBenefitAmount	353000000	USD
CY2017	jnj	Effective Income Tax Rate Reconciliation Sharebased Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationSharebasedCompensationExcessTaxBenefitPercent	0.018
CY2016Q1	jnj	Employee Obligations EmployeeObligations	9271000000	USD
CY2017Q1	jnj	Employee Obligations EmployeeObligations	10027000000	USD
CY2016	jnj	Excess Of Fair Value Over Carrying Value Of Debt ExcessOfFairValueOverCarryingValueOfDebt	1700000000	USD
CY2016Q4	jnj	Litigation Income Expense Net After Tax LitigationIncomeExpenseNetAfterTax	-46000000	USD
CY2017Q1	jnj	Litigation Income Expense Net After Tax LitigationIncomeExpenseNetAfterTax	-80000000	USD
CY2017	jnj	Minimum Collateral Valueasa Percent Reverse Repurchase Agreement MinimumCollateralValueasaPercentReverseRepurchaseAgreement	1.02
CY2017	jnj	Number Of Employees Engaged In Company Activities Worldwide NumberOfEmployeesEngagedInCompanyActivitiesWorldwide	126400	Employee
CY2016Q2	jnj	Litigation Income Expense Net After Tax LitigationIncomeExpenseNetAfterTax	-56000000	USD
CY2016Q3	jnj	Litigation Income Expense Net After Tax LitigationIncomeExpenseNetAfterTax	-493000000	USD
CY2017	jnj	Excess Of Fair Value Over Carrying Value Of Debt ExcessOfFairValueOverCarryingValueOfDebt	1600000000	USD
CY2016Q1	jnj	Fair Value Of Companys Common Stock Directly Held In Plan Assets FairValueOfCompanysCommonStockDirectlyHeldInPlanAssets	751000000	USD
CY2017Q1	jnj	Fair Value Of Companys Common Stock Directly Held In Plan Assets FairValueOfCompanysCommonStockDirectlyHeldInPlanAssets	847000000	USD
	jnj	Integrationcostsaftertax Integrationcostsaftertax	59000000	USD
CY2015Q1	jnj	Litigation And Recall Expense LitigationAndRecallExpense	139000000	USD
CY2015Q1	jnj	Litigation Income Expense Net After Tax LitigationIncomeExpenseNetAfterTax	253000000	USD
CY2015Q2	jnj	Litigation Income Expense Net After Tax LitigationIncomeExpenseNetAfterTax	-23000000	USD
CY2015Q3	jnj	Litigation Income Expense Net After Tax LitigationIncomeExpenseNetAfterTax	-348000000	USD
CY2017Q1	jnj	Number Of Stock Based Compensation Plans NumberOfStockBasedCompensationPlans	2
CY2014	jnj	Other Comprehensive Income Loss Pension And Other Effects Of Exchange Rate Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherEffectsOfExchangeRateNetOfTax	-197000000	USD
CY2016	jnj	Other Comprehensive Income Loss Pension And Other Effects Of Exchange Rate Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherEffectsOfExchangeRateNetOfTax	-148000000	USD
CY2017	jnj	Other Comprehensive Income Loss Pension And Other Effects Of Exchange Rate Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherEffectsOfExchangeRateNetOfTax	-159000000	USD
CY2014	jnj	Other Comprehensive Income Loss Pensionand Other Postretirement Benefit Plans Net Prior Service Cost Credit Netof Amortization Arising During Period Netof Tax OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax	-193000000	USD
CY2016	jnj	Other Comprehensive Income Loss Pensionand Other Postretirement Benefit Plans Net Prior Service Cost Credit Netof Amortization Arising During Period Netof Tax OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax	60000000	USD
CY2017	jnj	Other Comprehensive Income Loss Pensionand Other Postretirement Benefit Plans Net Prior Service Cost Credit Netof Amortization Arising During Period Netof Tax OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax	-21000000	USD
CY2014	jnj	Other Comprehensive Income Loss Reclassification Adjustmentfrom Aoci Pensionand Other Postretirement Benefit Plansfor Net Gain Loss Netof Amortization Netof Tax OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax	3698000000	USD
CY2016	jnj	Other Comprehensive Income Loss Reclassification Adjustmentfrom Aoci Pensionand Other Postretirement Benefit Plansfor Net Gain Loss Netof Amortization Netof Tax OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax	-931000000	USD
CY2017	jnj	Other Comprehensive Income Loss Reclassification Adjustmentfrom Aoci Pensionand Other Postretirement Benefit Plansfor Net Gain Loss Netof Amortization Netof Tax OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax	862000000	USD
CY2016Q1	jnj	Percentage Of Companys Common Stock To Plan Asset PercentageOfCompanysCommonStockToPlanAsset	0.034
CY2017Q1	jnj	Percentage Of Companys Common Stock To Plan Asset PercentageOfCompanysCommonStockToPlanAsset	0.036
CY2017Q1	jnj	Percentage Of Corridor Of Greater Of Market Value Of Assets PercentageOfCorridorOfGreaterOfMarketValueOfAssets	0.10
CY2014	jnj	Potential Shares Exercisable Under Stock Option Plans PotentialSharesExercisableUnderStockOptionPlans	142600000	shares
CY2016	jnj	Potential Shares Exercisable Under Stock Option Plans PotentialSharesExercisableUnderStockOptionPlans	141500000	shares
CY2017	jnj	Potential Shares Exercisable Under Stock Option Plans PotentialSharesExercisableUnderStockOptionPlans	142400000	shares
CY2014	jnj	Proceeds From Exercise Of Stock Options And Excess Tax Benefits ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits	1543000000	USD
CY2016	jnj	Proceeds From Exercise Of Stock Options And Excess Tax Benefits ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits	1005000000	USD
CY2017	jnj	Proceeds From Exercise Of Stock Options And Excess Tax Benefits ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits	1189000000	USD
CY2015Q1	jnj	Recall Costs After Tax RecallCostsAfterTax	122000000	USD
	jnj	Researchanddevelopmentaftertax Researchanddevelopmentaftertax	156000000	USD
CY2014	jnj	Sales Return Reserve SalesReturnReserve	0.010
CY2016	jnj	Sales Return Reserve SalesReturnReserve	0.010
CY2017	jnj	Sales Return Reserve SalesReturnReserve	0.010
CY2014	jnj	Shares Which Could Be Repurchased Under Treasury Stock Method SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod	96500000	shares
CY2016	jnj	Shares Which Could Be Repurchased Under Treasury Stock Method SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod	102600000	shares
CY2017	jnj	Shares Which Could Be Repurchased Under Treasury Stock Method SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod	92100000	shares
CY2017	jnj	Shippingand Handling Costsasa Percentof Sales ShippingandHandlingCostsasaPercentofSales	0.005
CY2014	jnj	Treasury Stock Issued For Employee Compensation And Stock Option Plans Net Of Cash Proceeds TreasuryStockIssuedForEmployeeCompensationAndStockOptionPlansNetOfCashProceeds	1409000000	USD
CY2016	jnj	Treasury Stock Issued For Employee Compensation And Stock Option Plans Net Of Cash Proceeds TreasuryStockIssuedForEmployeeCompensationAndStockOptionPlansNetOfCashProceeds	1486000000	USD
CY2017	jnj	Treasury Stock Issued For Employee Compensation And Stock Option Plans Net Of Cash Proceeds TreasuryStockIssuedForEmployeeCompensationAndStockOptionPlansNetOfCashProceeds	2043000000	USD
CY2014	jnj	Venezuela Currency Devaluation VenezuelaCurrencyDevaluation	87000000	USD
CY2016	jnj	Venezuela Currency Devaluation VenezuelaCurrencyDevaluation	122000000	USD
CY2017Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-14901000000	USD
CY2014	us-gaap	Advertising Expense AdvertisingExpense	2600000000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	12087000000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	12144000000	USD
CY2017	jnj	Venezuela Currency Devaluation VenezuelaCurrencyDevaluation	0	USD
CY2016Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	6668000000	USD
CY2017Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	6918000000	USD
CY2016Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	10734000000	USD
CY2017Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	11699000000	USD
CY2016Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	750000000	USD
CY2017Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	971000000	USD
CY2016Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5411000000	USD
CY2017Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5635000000	USD
CY2016Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	20743000000	USD
CY2017Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	21861000000	USD
CY2017Q1	us-gaap	Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax	-285000000	USD
CY2016Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-13165000000	USD
CY2016	us-gaap	Advertising Expense AdvertisingExpense	2500000000	USD
CY2017	us-gaap	Advertising Expense AdvertisingExpense	2400000000	USD
CY2014	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	792000000	USD
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	874000000	USD
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	878000000	USD
CY2016Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	268000000	USD
CY2017Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	252000000	USD
CY2014	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1400000000	USD
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1200000000	USD
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1200000000	USD
CY2014	us-gaap	Asset Impairment Charges AssetImpairmentCharges	410000000	USD
CY2016	us-gaap	Asset Impairment Charges AssetImpairmentCharges	624000000	USD
CY2017	us-gaap	Asset Impairment Charges AssetImpairmentCharges	283000000	USD
CY2016Q1	us-gaap	Assets Assets	133411000000	USD
CY2017Q1	us-gaap	Assets Assets	141208000000	USD
CY2016Q1	us-gaap	Assets Current AssetsCurrent	60210000000	USD
CY2017Q1	us-gaap	Assets Current AssetsCurrent	65032000000	USD
CY2016Q1	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	24644000000	USD
CY2017Q1	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	22935000000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	240000000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	232000000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	11430000000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	11381000000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	474000000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	474000000	USD
CY2016Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	9829000000	USD
CY2017Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	10112000000	USD
CY2017	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	5240000000	USD
CY2016Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	210000000	USD
	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	83000000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20927000000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14523000000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13732000000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18972000000	USD
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-6404000000	USD
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-791000000	USD
CY2014	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	2.76
CY2016	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	2.95
CY2017	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	3.15
CY2016Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1
CY2017Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1
CY2016Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4320000000	shares
CY2017Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4320000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3119843000	shares
CY2016Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3119843000	shares
CY2017Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3119843000	shares
CY2016Q1	us-gaap	Common Stock Value CommonStockValue	3120000000	USD
CY2017Q1	us-gaap	Common Stock Value CommonStockValue	3120000000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	8461000000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	12966000000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	14804000000	USD
CY2016Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	3528000000	USD
CY2017Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	3354000000	USD
CY2014	us-gaap	Cost Of Goods Sold CostOfGoodsSold	22746000000	USD
CY2016	us-gaap	Cost Of Goods Sold CostOfGoodsSold	21536000000	USD
CY2017	us-gaap	Cost Of Goods Sold CostOfGoodsSold	21685000000	USD
CY2014	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	2625000000	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	2748000000	USD
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1896000000	USD
CY2014	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1174000000	USD
CY2016	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1309000000	USD
CY2017	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1708000000	USD
CY2014	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	3799000000	USD
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	4057000000	USD
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	3604000000	USD
CY2014	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	17000000	USD
CY2016	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	16000000	USD
CY2017	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	35000000	USD
CY2016Q1	us-gaap	Debt Current DebtCurrent	7000000000	USD
CY2017Q1	us-gaap	Debt Current DebtCurrent	4700000000	USD
CY2016Q1	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0406
CY2017Q1	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0333
CY2016Q1	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	584000000	USD
CY2017Q1	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	534000000	USD
CY2014	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-258000000	USD
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	37000000	USD
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	294000000	USD
CY2014	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	699000000	USD
CY2016	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-307000000	USD
CY2017	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-635000000	USD
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	441000000	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-270000000	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-341000000	USD
CY2016Q1	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	960000000	USD
CY2017Q1	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	1309000000	USD
CY2016Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	10087000000	USD
CY2017Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	10144000000	USD
CY2016Q1	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	5490000000	USD
CY2017Q1	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	6148000000	USD
CY2016Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	997000000	USD
CY2017Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	717000000	USD
CY2016Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	922000000	USD
CY2017Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1135000000	USD
CY2016Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	2863000000	USD
CY2017Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	2958000000	USD
CY2016Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	790000000	USD
CY2017Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	749000000	USD
CY2016Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	1801000000	USD
CY2017Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	1857000000	USD
CY2016Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	196000000	USD
CY2016Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	7159000000	USD
CY2017Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	6906000000	USD
CY2016Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	6663000000	USD
CY2017Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	6672000000	USD
CY2016Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	2562000000	USD
CY2017Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	2910000000	USD
CY2016Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	249000000	USD
CY2017Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	15000000	USD
CY2016Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	247000000	USD
CY2017Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	219000000	USD
CY2016Q1	us-gaap	Defined Benefit Pension Plan Current And Noncurrent Liabilities DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities	3857000000	USD
CY2017Q1	us-gaap	Defined Benefit Pension Plan Current And Noncurrent Liabilities DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities	4710000000	USD
CY2017	us-gaap	Defined Benefit Plan Amortization Of Net Transition Asset Obligation DefinedBenefitPlanAmortizationOfNetTransitionAssetObligation	0	USD
CY2016Q1	us-gaap	Defined Benefit Plan Assets For Plan Benefits Noncurrent DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent	256000000	USD
CY2017Q1	us-gaap	Defined Benefit Plan Assets For Plan Benefits Noncurrent DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent	227000000	USD
CY2017	us-gaap	Defined Benefit Plan Effect Of One Percentage Point Decrease On Accumulated Postretirement Benefit Obligation1 DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnAccumulatedPostretirementBenefitObligation1	325000000	USD
CY2017	us-gaap	Defined Benefit Plan Effect Of One Percentage Point Decrease On Service And Interest Cost Components1 DefinedBenefitPlanEffectOfOnePercentagePointDecreaseOnServiceAndInterestCostComponents1	23000000	USD
CY2017	us-gaap	Defined Benefit Plan Effect Of One Percentage Point Increase On Accumulated Postretirement Benefit Obligation DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnAccumulatedPostretirementBenefitObligation	401000000	USD
CY2017	us-gaap	Defined Benefit Plan Effect Of One Percentage Point Increase On Service And Interest Cost Components DefinedBenefitPlanEffectOfOnePercentagePointIncreaseOnServiceAndInterestCostComponents	30000000	USD
CY2017	us-gaap	Defined Benefit Plan Future Amortization Of Gain Loss DefinedBenefitPlanFutureAmortizationOfGainLoss	-715000000	USD
CY2017	us-gaap	Defined Benefit Plan Future Amortization Of Prior Service Cost Credit DefinedBenefitPlanFutureAmortizationOfPriorServiceCostCredit	-28000000	USD
CY2016	us-gaap	Defined Benefit Plan Health Care Cost Trend Rate Assumed For Next Fiscal Year DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYear	0.0660
CY2017	us-gaap	Defined Benefit Plan Health Care Cost Trend Rate Assumed For Next Fiscal Year DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYear	0.0632
CY2016	us-gaap	Defined Benefit Plan Measurement Date DefinedBenefitPlanMeasurementDate	December 31, 2015
CY2017	us-gaap	Defined Benefit Plan Measurement Date DefinedBenefitPlanMeasurementDate	December 31, 2016
CY2016Q1	us-gaap	Defined Benefit Plan Pension Plans With Accumulated Benefit Obligations In Excess Of Plan Assets Aggregate Accumulated Benefit Obligation DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation	4500000000	USD
CY2017Q1	us-gaap	Defined Benefit Plan Pension Plans With Accumulated Benefit Obligations In Excess Of Plan Assets Aggregate Accumulated Benefit Obligation DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation	8800000000	USD
CY2016Q1	us-gaap	Defined Benefit Plan Pension Plans With Accumulated Benefit Obligations In Excess Of Plan Assets Aggregate Fair Value Of Plan Assets DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets	1900000000	USD
CY2017Q1	us-gaap	Defined Benefit Plan Pension Plans With Accumulated Benefit Obligations In Excess Of Plan Assets Aggregate Fair Value Of Plan Assets DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets	5600000000	USD
CY2016Q1	us-gaap	Defined Benefit Plan Pension Plans With Accumulated Benefit Obligations In Excess Of Plan Assets Aggregate Projected Benefit Obligation DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation	5300000000	USD
CY2017Q1	us-gaap	Defined Benefit Plan Pension Plans With Accumulated Benefit Obligations In Excess Of Plan Assets Aggregate Projected Benefit Obligation DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation	9900000000	USD
CY2017	us-gaap	Defined Benefit Plan Target Plan Asset Allocations DefinedBenefitPlanTargetPlanAssetAllocations	1.00
CY2016	us-gaap	Defined Benefit Plan Ultimate Health Care Cost Trend Rate DefinedBenefitPlanUltimateHealthCareCostTrendRate	0.0450
CY2017	us-gaap	Defined Benefit Plan Ultimate Health Care Cost Trend Rate DefinedBenefitPlanUltimateHealthCareCostTrendRate	0.0450
CY2016Q1	us-gaap	Defined Benefit Plan Weighted Average Asset Allocations DefinedBenefitPlanWeightedAverageAssetAllocations	1.00
CY2017Q1	us-gaap	Defined Benefit Plan Weighted Average Asset Allocations DefinedBenefitPlanWeightedAverageAssetAllocations	1.00
CY2016Q1	us-gaap	Defined Benefit Plan Year That Rate Reaches Ultimate Trend Rate DefinedBenefitPlanYearThatRateReachesUltimateTrendRate	2038
CY2017Q1	us-gaap	Defined Benefit Plan Year That Rate Reaches Ultimate Trend Rate DefinedBenefitPlanYearThatRateReachesUltimateTrendRate	2038
CY2014	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	172000000	USD
CY2016	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	187000000	USD
CY2017	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	191000000	USD
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3895000000	USD
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3746000000	USD
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3754000000	USD
CY2014	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	7768000000	USD
CY2016	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	8173000000	USD
CY2017	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	8621000000	USD
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.80
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.55
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.63
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.21
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.16
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.56
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.62
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.46
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.56
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.41
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	6.04
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.70
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.53
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.61
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.20
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.15
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.48
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.59
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.43
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.53
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.38
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.93
CY2014	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-310000000	USD
CY2016	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-1489000000	USD
CY2017	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-215000000	USD
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.197
CY2014	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.206
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.165
CY2014	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.032
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Deductions Other EffectiveIncomeTaxRateReconciliationDeductionsOther	0.000
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Deductions Other EffectiveIncomeTaxRateReconciliationDeductionsOther	0.000
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Deductions Other EffectiveIncomeTaxRateReconciliationDeductionsOther	0.018
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities	0.006
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities	0.006
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Deductions Qualified Production Activities EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities	0.006
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Assets EffectiveIncomeTaxRateReconciliationDispositionOfAssets	-0.019
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Assets EffectiveIncomeTaxRateReconciliationDispositionOfAssets	0.000
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Assets EffectiveIncomeTaxRateReconciliationDispositionOfAssets	0.000
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.070
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.067
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.094
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.001
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.003
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.003
CY2014	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.010
CY2016	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.004
CY2017	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.001
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.003
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.002
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.004
CY2016Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2474000000	USD
CY2017Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2676000000	USD
CY2014Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	722000000	USD
CY2016Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	744000000	USD
CY2017Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	749000000	USD
CY2014	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y2M5D
CY2016	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P11M23D
CY2017	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y1M2D
CY2014	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	259000000	USD
CY2016	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	253000000	USD
CY2017	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	256000000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1500000000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1500000000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1500000000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1500000000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1500000000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1500000000	USD
CY2014	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-156000000	USD
CY2016	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-104000000	USD
CY2017	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-289000000	USD
CY2014	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	2400000000	USD
CY2016	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	2600000000	USD
CY2017	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	600000000	USD
CY2016	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	-34000000	USD
CY2017	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	-56000000	USD
CY2014	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	2383000000	USD
CY2016	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	2583000000	USD
CY2017	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	563000000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	21832000000	USD
CY2016Q1	us-gaap	Goodwill Goodwill	21629000000	USD
CY2017Q1	us-gaap	Goodwill Goodwill	22805000000	USD
CY2016	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	510000000	USD
CY2017	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	1572000000	USD
CY2016	us-gaap	Goodwill Other Changes GoodwillOtherChanges	520000000	USD
CY2017	us-gaap	Goodwill Other Changes GoodwillOtherChanges	321000000	USD
CY2016	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	193000000	USD
CY2017	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	75000000	USD
CY2014	us-gaap	Gross Profit GrossProfit	51585000000	USD
CY2015Q1	us-gaap	Gross Profit GrossProfit	12092000000	USD
CY2015Q2	us-gaap	Gross Profit GrossProfit	12430000000	USD
CY2015Q3	us-gaap	Gross Profit GrossProfit	11878000000	USD
	us-gaap	Gross Profit GrossProfit	12138000000	USD
CY2016	us-gaap	Gross Profit GrossProfit	48538000000	USD
CY2016Q2	us-gaap	Gross Profit GrossProfit	12153000000	USD
CY2016Q3	us-gaap	Gross Profit GrossProfit	13146000000	USD
CY2016Q4	us-gaap	Gross Profit GrossProfit	12334000000	USD
CY2017Q1	us-gaap	Gross Profit GrossProfit	12572000000	USD
CY2017	us-gaap	Gross Profit GrossProfit	50205000000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	8001000000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	8179000000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	7457000000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	12562000000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	11017000000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	12346000000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	20563000000	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	5575000000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	5741000000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	4122000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	3758000000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	19196000000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	5294000000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	4904000000	USD
CY2016Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	5281000000	USD
CY2017Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	4324000000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3263000000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	19803000000	USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4240000000	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3787000000	USD
CY2014	us-gaap	Income Taxes Paid IncomeTaxesPaid	3536000000	USD
CY2016	us-gaap	Income Taxes Paid IncomeTaxesPaid	2865000000	USD
CY2017	us-gaap	Income Taxes Paid IncomeTaxesPaid	2843000000	USD
CY2014	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1194000000	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	287000000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	656000000	USD
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	247000000	USD
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	433000000	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1065000000	USD
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1120000000	USD
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	449000000	USD
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	249000000	USD
CY2014	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-442000000	USD
CY2016	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-65000000	USD
CY2017	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-18000000	USD
CY2014	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1096000000	USD
CY2016	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	2159000000	USD
CY2017	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1133000000	USD
CY2014	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	2600000	shares
CY2016	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	2200000	shares
CY2017	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	1300000	shares
CY2016Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	10443000000	USD
CY2017Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	10331000000	USD
CY2016Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	25764000000	USD
CY2017Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	26876000000	USD
CY2014	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	115000000	USD
CY2016	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	102000000	USD
CY2017	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	102000000	USD
CY2014	us-gaap	Interest Expense InterestExpense	533000000	USD
CY2016	us-gaap	Interest Expense InterestExpense	552000000	USD
CY2017	us-gaap	Interest Expense InterestExpense	726000000	USD
CY2014	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	3000000	USD
CY2016	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	3000000	USD
CY2017	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	2000000	USD
CY2014	us-gaap	Interest Paid InterestPaid	603000000	USD
CY2016	us-gaap	Interest Paid InterestPaid	617000000	USD
CY2017	us-gaap	Interest Paid InterestPaid	730000000	USD
CY2014	us-gaap	Interest Paid Net InterestPaidNet	488000000	USD
CY2016	us-gaap	Interest Paid Net InterestPaidNet	515000000	USD
CY2017	us-gaap	Interest Paid Net InterestPaidNet	628000000	USD
CY2016Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	4876000000	USD
CY2017Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	5007000000	USD
CY2016Q1	us-gaap	Inventory Net InventoryNet	8053000000	USD
CY2017Q1	us-gaap	Inventory Net InventoryNet	8144000000	USD
CY2016Q1	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	936000000	USD
CY2017Q1	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	952000000	USD
CY2016Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2241000000	USD
CY2017Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2185000000	USD
CY2014	us-gaap	Investment Income Interest InvestmentIncomeInterest	67000000	USD
CY2016	us-gaap	Investment Income Interest InvestmentIncomeInterest	128000000	USD
CY2017	us-gaap	Investment Income Interest InvestmentIncomeInterest	368000000	USD
CY2016Q1	us-gaap	Land Land	780000000	USD
CY2017Q1	us-gaap	Land Land	753000000	USD
CY2014	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	341000000	USD
CY2016	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	316000000	USD
CY2017	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	330000000	USD
CY2016Q1	us-gaap	Liabilities Liabilities	62261000000	USD
CY2017Q1	us-gaap	Liabilities Liabilities	70790000000	USD
CY2016Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	133411000000	USD
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	141208000000	USD
CY2016Q1	us-gaap	Liabilities Current LiabilitiesCurrent	27747000000	USD
CY2017Q1	us-gaap	Liabilities Current LiabilitiesCurrent	26287000000	USD
CY2017	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2017-09-14
CY2017	us-gaap	Line Of Credit Facility Initiation Date1 LineOfCreditFacilityInitiationDate1	2016-09-15
CY2017Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	10000000000	USD
CY2014	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	1253000000	USD
CY2015Q2	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	134000000	USD
CY2015Q3	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	409000000	USD
CY2016	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	141000000	USD
CY2016Q2	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	66000000	USD
CY2016Q3	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	600000000	USD
CY2016Q4	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	55000000	USD
CY2017Q1	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	96000000	USD
CY2016Q1	us-gaap	Long Term Commercial Paper Current LongTermCommercialPaperCurrent	4600000000	USD
CY2017Q1	us-gaap	Long Term Commercial Paper Current LongTermCommercialPaperCurrent	2700000000	USD
CY2017Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	15919000000	USD
CY2017Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1704000000	USD
CY2017Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	1795000000	USD
CY2017Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	629000000	USD
CY2017Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	2538000000	USD
CY2017Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	1561000000	USD
CY2016Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	12857000000	USD
CY2017Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	22442000000	USD
CY2016Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	22511000000	USD
CY2017Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	23554000000	USD
CY2016Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	24644000000	USD
CY2017Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	22935000000	USD
CY2017	us-gaap	Maximum Length Of Time Foreign Currency Cash Flow Hedge MaximumLengthOfTimeForeignCurrencyCashFlowHedge	P18M
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-12499000000	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-11136000000	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-8551000000	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12305000000	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7735000000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4761000000	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	18710000000	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	19569000000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	18767000000	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	16323000000	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	4320000000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	4516000000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	3358000000	USD
	us-gaap	Net Income Loss NetIncomeLoss	3215000000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	15409000000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	4457000000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	3997000000	USD
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	4272000000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	3814000000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	16540000000	USD
CY2014	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	2129000000	USD
CY2016	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	954000000	USD
CY2017	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	4509000000	USD
CY2014	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	2167000000	USD
CY2016	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	1174000000	USD
CY2017	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	4586000000	USD
CY2014	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	38000000	USD
CY2016	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	220000000	USD
CY2017	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	77000000	USD
CY2017	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	Segment
CY2017Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	822000000	USD
CY2017Q1	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	216000000	USD
CY2017Q1	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	88000000	USD
CY2017Q1	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	105000000	USD
CY2017Q1	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	134000000	USD
CY2017Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	179000000	USD
CY2017Q1	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	100000000	USD
CY2016Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4413000000	USD
CY2017Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4435000000	USD
CY2014	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	-4601000000	USD
CY2016	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	-3632000000	USD
CY2017	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	-612000000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	151000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	347000000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-193000000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-104000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-177000000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-249000000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-7862000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2443000000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1736000000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	3308000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-1019000000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	682000000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	1556000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	519000000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	346000000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	5000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	124000000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	141000000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	196000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	62000000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	-110000000	USD
CY2014	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	92000000	USD
CY2016	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-115000000	USD
CY2017	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-359000000	USD
CY2014	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	56000000	USD
CY2016	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	95000000	USD
CY2017	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	134000000	USD
CY2014	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	156000000	USD
CY2016	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	471000000	USD
CY2017	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-52000000	USD
CY2014	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	81000000	USD
CY2016	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	187000000	USD
CY2017	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	104000000	USD
CY2016Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10241000000	USD
CY2017Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	9536000000	USD
CY2014	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	70000000	USD
CY2016	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2064000000	USD
CY2017	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-484000000	USD
CY2016Q1	us-gaap	Other Postretirement Defined Benefit Plan Liabilities Current And Noncurrent OtherPostretirementDefinedBenefitPlanLiabilitiesCurrentAndNoncurrent	2738000000	USD
CY2017Q1	us-gaap	Other Postretirement Defined Benefit Plan Liabilities Current And Noncurrent OtherPostretirementDefinedBenefitPlanLiabilitiesCurrentAndNoncurrent	2733000000	USD
CY2016	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	-400000000	USD
CY2014	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	299000000	USD
CY2016	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	103000000	USD
CY2017	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	123000000	USD
CY2014	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	7124000000	USD
CY2016	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5290000000	USD
CY2017	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	8979000000	USD
CY2014	us-gaap	Payments Of Ordinary Dividends PaymentsOfOrdinaryDividends	7768000000	USD
CY2016	us-gaap	Payments Of Ordinary Dividends PaymentsOfOrdinaryDividends	8173000000	USD
CY2017	us-gaap	Payments Of Ordinary Dividends PaymentsOfOrdinaryDividends	8621000000	USD
CY2014	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	2129000000	USD
CY2016	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	954000000	USD
CY2017	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	4509000000	USD
CY2014	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-28000000	USD
CY2014	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	34913000000	USD
CY2016	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	40828000000	USD
CY2017	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	33950000000	USD
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3714000000	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3463000000	USD
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3226000000	USD
CY2016Q1	us-gaap	Pension And Other Postretirement Defined Benefit Plans Current Liabilities PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities	417000000	USD
CY2017Q1	us-gaap	Pension And Other Postretirement Defined Benefit Plans Current Liabilities PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities	412000000	USD
CY2016Q1	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	8854000000	USD
CY2017Q1	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	9615000000	USD
CY2016Q1	us-gaap	Postemployment Benefits Liability Current And Noncurrent PostemploymentBenefitsLiabilityCurrentAndNoncurrent	2092000000	USD
CY2017Q1	us-gaap	Postemployment Benefits Liability Current And Noncurrent PostemploymentBenefitsLiabilityCurrentAndNoncurrent	2050000000	USD
CY2016Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2017Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2016Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2017Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2016Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3047000000	USD
CY2017Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3282000000	USD
CY2014	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	2098000000	USD
CY2016	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	75000000	USD
CY2017	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	12004000000	USD
CY2014	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
CY2016	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-57000000	USD
CY2017	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-15000000	USD
CY2014	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	24119000000	USD
CY2016	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	34149000000	USD
CY2017	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	35780000000	USD
CY2014	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	4631000000	USD
CY2016	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	3464000000	USD
CY2017	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	1267000000	USD
CY2014	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	1863000000	USD
CY2016	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	2416000000	USD
CY2017	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	111000000	USD
CY2014	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	3714000000	USD
CY2016	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	3463000000	USD
CY2017	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	3226000000	USD
CY2016Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	36648000000	USD
CY2017Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	37773000000	USD
CY2016Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15905000000	USD
CY2017Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15912000000	USD
CY2016	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	18000000	USD
CY2017	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-11000000	USD
CY2014	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1844000000	USD
CY2016	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	68000000	USD
CY2017	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2223000000	USD
CY2014	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	1267000000	USD
CY2016	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	1044000000	USD
CY2017	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	2017000000	USD
CY2014	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	8494000000	USD
CY2016	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	9046000000	USD
CY2017	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	9095000000	USD
CY2014	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	178000000	USD
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	214000000	USD
CY2016	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	224000000	USD
CY2017	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	29000000	USD
CY2014	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2016	us-gaap	Restructuring Charges RestructuringCharges	509000000	USD
CY2017	us-gaap	Restructuring Charges RestructuringCharges	491000000	USD
CY2016Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	103879000000	USD
CY2017Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	110551000000	USD
CY2014	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	74331000000	USD
CY2015Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	17374000000	USD
CY2015Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	17787000000	USD
CY2015Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	17102000000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	17811000000	USD
CY2016	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	70074000000	USD
CY2016Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	17482000000	USD
CY2016Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	18482000000	USD
CY2016Q4	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	17820000000	USD
CY2017Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	18106000000	USD
CY2017	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	71890000000	USD
CY2014	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	21954000000	USD
CY2016	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	21203000000	USD
CY2017	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	19945000000	USD
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	792000000	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	874000000	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	878000000	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0310
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0290
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0310
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.1460
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.1548
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.1576
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0187
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0177
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0151
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	57846000	shares
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	48345000	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	61.94
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	62.26
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	954000000	USD
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	644000000	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	980000000	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	2881000	shares
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	2996000	shares
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	3006000	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	24356000	shares
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	20484000	shares
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	22491000	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	8.42
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	10.68
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	10.01
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3306000000	USD
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4014000000	USD
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3065000000	USD
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3636000000	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	119556000	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	115712000	shares
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	116517000	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	113455000	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	64.70
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	70.37
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	76.41
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	83.16
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	62.31
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	62.53
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	65.66
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	75.48
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	82.22
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	92.83
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	90.44
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	100.06
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	101.87
CY2017Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	50414000	shares
CY2014Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	115712000	shares
CY2016Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	116517000	shares
CY2017Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	113455000	shares
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y
CY2017Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	65.77
CY2017Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	83.16
CY2014	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P5Y8M12D
CY2016	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P5Y10M24D
CY2017	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P6Y2M12D
CY2014	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	1068000000	USD
CY2016	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	996000000	USD
CY2017	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	974000000	USD
CY2016Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	7004000000	USD
CY2017Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	4684000000	USD
CY2014	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	32302000	shares
CY2016	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	24413000	shares
CY2017	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	30839000	shares
CY2014	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	25319000	shares
CY2016	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	16683000	shares
CY2017	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	22547000	shares
CY2014	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	2933000000	USD
CY2016	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	2497000000	USD
CY2017	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	3311000000	USD
CY2014	us-gaap	Stock Issued During Period Value Treasury Stock Reissued StockIssuedDuringPeriodValueTreasuryStockReissued	2164000000	USD
CY2016	us-gaap	Stock Issued During Period Value Treasury Stock Reissued StockIssuedDuringPeriodValueTreasuryStockReissued	1920000000	USD
CY2017	us-gaap	Stock Issued During Period Value Treasury Stock Reissued StockIssuedDuringPeriodValueTreasuryStockReissued	2130000000	USD
CY2016Q1	us-gaap	Stockholders Equity Before Treasury Stock StockholdersEquityBeforeTreasuryStock	93834000000	USD
CY2017Q1	us-gaap	Stockholders Equity Before Treasury Stock StockholdersEquityBeforeTreasuryStock	98770000000	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	74053000000	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	69752000000	USD
CY2016Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	71150000000	USD
CY2017Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	70418000000	USD
CY2014	us-gaap	Stockholders Equity Other StockholdersEquityOther	34000000	USD
CY2016	us-gaap	Stockholders Equity Other StockholdersEquityOther	25000000	USD
CY2017	us-gaap	Stockholders Equity Other StockholdersEquityOther	66000000	USD
CY2013Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	299215000	shares
CY2014Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	336620000	shares
CY2016Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	364681000	shares
CY2017Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	413332000	shares
CY2013Q4	us-gaap	Treasury Stock Value TreasuryStockValue	15700000000	USD
CY2014Q4	us-gaap	Treasury Stock Value TreasuryStockValue	19891000000	USD
CY2016Q1	us-gaap	Treasury Stock Value TreasuryStockValue	22684000000	USD
CY2017Q1	us-gaap	Treasury Stock Value TreasuryStockValue	28352000000	USD
CY2014	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	7124000000	USD
CY2016	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	5290000000	USD
CY2017	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	8979000000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2729000000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2465000000	USD
CY2016Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3080000000	USD
CY2017Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3041000000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	288000000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	79000000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	338000000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	477000000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	4000000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	37000000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	281000000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	570000000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	348000000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	295000000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	182000000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	11000000	USD
CY2016Q1	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	366000000	USD
CY2017Q1	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	344000000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	12000000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	44000000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	7000000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	75000000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	54000000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	23000000	USD
CY2014	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	100000000	USD
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2863900000	shares
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2812900000	shares
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2788900000	shares
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2815200000	shares
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2771800000	shares
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2737300000	shares
CY2017	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Concentration of Credit Risk</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Global concentration of credit risk with respect to trade accounts receivables continues to be limited due to the large number of customers globally and adherence to internal credit policies and credit limits. Economic challenges in Italy, Spain, Greece and Portugal (the Southern European Region) have impacted certain payment patterns, which have historically been longer than those experienced in the U.S. and other international markets. The total net trade accounts receivable balance in the Southern European Region was approximately </font><font style="font-family:inherit;font-size:10pt;">$1.1 billion</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">January 1, 2017</font><font style="font-family:inherit;font-size:10pt;"> and approximately </font><font style="font-family:inherit;font-size:10pt;">$1.3 billion</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">January 3, 2016</font><font style="font-family:inherit;font-size:10pt;">. Approximately </font><font style="font-family:inherit;font-size:10pt;">$0.7 billion</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">January 1, 2017</font><font style="font-family:inherit;font-size:10pt;"> and approximately </font><font style="font-family:inherit;font-size:10pt;">$0.8 billion</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">January 3, 2016</font><font style="font-family:inherit;font-size:10pt;"> of the Southern European Region net trade accounts receivable balance related to the Company's Consumer, Vision Care and Diabetes Care businesses as well as certain Pharmaceutical and Medical Devices customers which are in line with historical collection patterns.</font></div><div style="line-height:120%;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The remaining balance of net trade accounts receivable in the Southern European Region has been negatively impacted by the timing of payments from certain government owned or supported health care customers, as well as certain distributors of the Pharmaceutical and Medical Devices local affiliates. The total net trade accounts receivable balance for these customers were approximately </font><font style="font-family:inherit;font-size:10pt;">$0.4 billion</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">January 1, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.5 billion</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">January 3, 2016</font><font style="font-family:inherit;font-size:10pt;">. The Company continues to receive payments from these customers and, in some cases, late payments with interest. For customers where payment is expected over periods of time longer than one year, revenue and trade receivables have been discounted over the estimated period of time for collection. Allowances for doubtful accounts have been increased for these customers, but have been immaterial to date. The Company will continue to work closely with these customers on payment plans, monitor the economic situation and take appropriate actions as necessary.</font></div></div>
CY2017	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Description of the Company and Business Segments</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has approximately </font><font style="font-family:inherit;font-size:10pt;">126,400</font><font style="font-family:inherit;font-size:10pt;"> employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the health care field. The Company conducts business in virtually all countries of the world and its primary focus is on products related to human health and well-being.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is organized into </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;"> business segments: Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes a broad range of products used in the baby care, oral care, beauty (previously referred to as skin care), over-the-counter pharmaceutical, women’s health and wound care markets. These products are marketed to the general public and sold both to retail outlets and distributors throughout the world. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, hospitals and health care professionals for prescription use. The Medical Devices segment includes a broad range of products used in the orthopaedic, surgery, cardiovascular, diabetes care and vision care fields, which are distributed to wholesalers, hospitals and retailers, and used principally in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. </font></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>
CY2017	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reclassification</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain prior period amounts have been reclassified to conform to current year presentation.</font></div></div>
CY2017	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the amounts reported. Estimates are used when accounting for sales discounts, rebates, allowances and incentives, product liabilities, income taxes, depreciation, amortization, employee benefits, contingencies and intangible asset and liability valuations. Actual results may or may not differ from those estimates.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company follows the provisions of U.S. GAAP when recording litigation related contingencies. A liability is recorded when a loss is probable and can be reasonably estimated. The best estimate of a loss within a range is accrued; however, if no estimate in the range is better than any other, the minimum amount is accrued.</font></div></div>

Files In Submission

Name	View Source	Status
0000200406-17-000006-index-headers.html	Edgar Link	pending
0000200406-17-000006-index.html	Edgar Link	pending
0000200406-17-000006.txt	Edgar Link	pending
0000200406-17-000006-xbrl.zip	Edgar Link	pending
ex12-statementofcomputatio.htm	Edgar Link	pending
ex21-subsidiariesxform10xk.htm	Edgar Link	pending
ex23-pwcconsentxform10xkx2.htm	Edgar Link	pending
ex31a-302certofceoxform10x.htm	Edgar Link	pending
ex31b-302certofcfoxform10x.htm	Edgar Link	pending
ex32a-906certofceoxform10x.htm	Edgar Link	pending
ex32b-906certofcfoxform10x.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
form10-k20170101.htm	Edgar Link	pending
jnj-20170101.xml	Edgar Link	completed
jnj-20170101.xsd	Edgar Link	pending
jnj-20170101_cal.xml	Edgar Link	unprocessable
jnj-20170101_def.xml	Edgar Link	unprocessable
jnj-20170101_lab.xml	Edgar Link	unprocessable
jnj-20170101_pre.xml	Edgar Link	unprocessable
jnj10yearshareholdergraph16.jpg	Edgar Link	pending
jnj5yearshareholdergraph2016.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$JNJ
JOHNSON & JOHNSON Stock $jnj

2017 Q1 Form 10-K Financial Statement

#000020040617000006 Filed on February 27, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JNJ JOHNSON & JOHNSON Stock $jnj

2017 Q1 Form 10-K Financial Statement

#000020040617000006 Filed on February 27, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JNJ
JOHNSON & JOHNSON Stock $jnj